SOD2 and diabetes mellitus: Our further in vivo study showed that SOD2 mRNA expression was reduced to ~12% in the ASD group compared to the TD group, this is a very significant dramatic reduction in SOD2 expression, indicating that maternal diabetes and prenatal progestin exposure may play a dominant role for the contribution of ASD development.